All data are based on the daily closing price as of April 28, 2025
b
BioNote
377740.KO
3.15 USD
-0.04
-1.25%
Overview
Last close
3.15 usd
Market cap
318.82M usd
52 week high
4.56 usd
52 week low
2.83 usd
Target price
3.95 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
4.9273
Price/Book Value
0.2838
Enterprise Value
43.47M usd
EV/Revenue
0.6105
EV/EBITDA
0.7676
Key financials
Revenue TTM
65.28M usd
Gross Profit TTM
-6.02M usd
EBITDA TTM
-24.05M usd
Earnings per Share
N/A usd
Dividend
0.14 usd
Total assets
1.33B usd
Net debt
N/A usd
About
BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.